Disappearance of a chromosomal abnormality in a young patient with polycythemia vera treated with ropeginterferon alfa-2b

Ann Hematol. 2024 Sep;103(9):3825-3827. doi: 10.1007/s00277-024-05909-3. Epub 2024 Jul 25.

Authors

Rina Hosoda¹, Yoshinori Hashimoto², Kentaro Hara¹, Masaya Maegaki^{1

3}, Sayaka Suzuki^{1

3}, Yuzuru Hosoda^{1

3}, Koji Kawamura^{1

3}

Affiliations

¹ Department of Hematology, Tottori University Hospital, Tottori, Japan.
² Department of Hematology, Tottori Prefectural Central Hospital, 730 Ezu, Tottori CityTottori, 680-0901, Japan. 98069yh@jichi.ac.jp.
³ Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan.

PMID: 39052033
DOI: 10.1007/s00277-024-05909-3

No abstract available

Keywords: Chromosomal abnormality; Cytogenetic response; Molecular response; Polycythemia vera; Ropeginterferon alfa-2b.

Publication types

Letter
Case Reports

MeSH terms

Adult
Chromosome Aberrations
Humans
Interferon alpha-2* / therapeutic use
Interferon-alpha* / therapeutic use
Polycythemia Vera* / drug therapy
Polycythemia Vera* / genetics
Polyethylene Glycols* / therapeutic use
Recombinant Proteins* / therapeutic use

Substances

Interferon alpha-2
Interferon-alpha
peginterferon alfa-2b
Polyethylene Glycols
Recombinant Proteins